Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20170417033489N4Phase 2Completed
Phase 2, open-label, single-arm trial of platelet-rich plasma in vesicoureteral reflux (VUR), sponsored by Mashhad University of Medical Sciences. Primary endpoint: vesicoureteral reflux cure. Started May 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20170417033489N4.